Astex Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 5 of about 5   

Articles published

ASTX 0.0000
price chart
In re Astex Pharmaceuticals, Inc. S'holders Litig., Consol. C.A. No. 8917-VCL ...
The stockholder class action at issue challenged the acquisition of Astex Pharmaceuticals Inc. (�Astex�) by Otsuka Holdings Co.
Chancery Won't End Astex Buyout Case, Citing Lack Of Notice
Law360, New York (August 26, 2014, 7:08 PM ET) -- A Delaware Chancery Court judge declined Monday to close a consolidated shareholder class action challenging Astex Pharmaceuticals Inc.'s planned $886 million buyout by Japanese drugmaker Otsuka ...
Related articles »  
InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic ...
InnoPharma developed the generic formulation of decitabine for injection and entered into an agreement with Sandoz, Inc., pursuant to which Sandoz will sell, market and distribute decitabine for injection in the United States.
Related articles »  
InnoPharma's decitabine for injection receives US FDA approval for treatment ...
InnoPharma, Inc., a privately held, sterile product development company, announced that its Abbreviated New Drug Application (ANDA) for decitabine for injection, a generic version of Eisai Inc.'s Dacogen has received the approval from the US Food and ...
Related articles »  
Array BioPharma Reports Financial Results For The Fourth Quarter And Full ...
At the meeting, preliminary data for the combination of binimetinib and CDK4/6 inhibitor LEE011 (discovered by Novartis Institutes for BioMedical Research in collaboration with Astex Pharmaceuticals) was presented. The data from this Phase 1b/2 ...
Related articles »